We are live on ! Find out more
SC

Stance Capital Portfolio holdings

AUM $206M
1-Year Est. Return 22.76%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+22.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$266M
AUM Growth
+$131M
Cap. Flow
+$117M
Cap. Flow %
43.89%
Top 10 Hldgs %
19.2%
Holding
179
New
135
Increased
5
Reduced
18
Closed
21

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$4.09M
2
CSCO icon
Cisco
CSCO
+$3.94M
3
SYK icon
Stryker
SYK
+$3.92M
4
WBA
Walgreens Boots Alliance
WBA
+$3.68M
5
NFLX icon
Netflix
NFLX
+$3.52M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$4.96M
2
MCK icon
McKesson
MCK
+$4.92M
3
IBM icon
IBM
IBM
+$4.39M
4
ED icon
Consolidated Edison
ED
+$4.38M
5
CTSH icon
Cognizant
CTSH
+$4.24M

Sector Composition

Rank Sector Weight
1 Technology 22.97%
2 Consumer Discretionary 15.38%
3 Financials 12.24%
4 Healthcare 12.08%
5 Industrials 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
176
Target
TGT
$65.7B
-29,311
Closed -$3.06M
XEL icon
177
Xcel Energy
XEL
$51.3B
-18,716
Closed -$1.32M
GEV icon
178
GE Vernova
GEV
$247B
-1,301
Closed -$397K
SW
179
Smurfit Westrock
SW
$26.9B
-23,304
Closed -$1.05M

Similar funds

Stance Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Stance Capital held 179 positions worth $266M, up 97% from $135M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Stance Capital deployed $117M of net new capital in Q2 2025, opening 135 new positions and adding to 5 existing holdings. Its largest new stake was TJX Companies: 32,238 shares worth $3.98M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Boston Scientific, an estimated $3.93M trimmed.

  • Stance Capital's largest Q2 2025 buy was TJX Companies: 32,238 shares worth $3.98M.
  • Stance Capital added most to Dell in Q2 2025, an estimated $868K increase.
  • Stance Capital's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $3.93M.
  • Stance Capital fully exited HCA Healthcare in Q2 2025, selling an estimated $4.96M.
  • Stance Capital's ten largest holdings make up 19% of its $266M portfolio in Q2 2025.
  • Stance Capital opened 135 new positions and closed 21 in Q2 2025.
  • Stance Capital's portfolio value rose 97% quarter-over-quarter to $266M.

Based on Stance Capital's 13F filing for Q2 2025, filed 22 Aug 2025.